S:  Susceptible;  susceptible (uninfected);  fraction of population in susceptible stage;  Susceptible individuals;  fraction of the population in each stage at day 1; 
I:  Infected;  infected (asymptomatic or pauci-symptomatic infected, undetected);  fraction of population in infected stage;  Infected individuals;  number of diagnosed individuals who recovered;  fraction of the population in each stage at day 1; 
D:  Diagnosed;  diagnosed (asymptomatic infected, detected);  fraction of population in diagnosed stage;  Infected individuals;  fraction of the population in each stage at day 1; 
A:  Ailing;  ailing (symptomatic infected, undetected);  fraction of population in ailing stage;  Infected individuals;  fraction of the population in each stage at day 1; 
R:  Recognized;  recognized (symptomatic infected, detected);  fraction of population in recognized stage;  Infected individuals;  fraction of the population in each stage at day 1; 
T:  Threatened;  threatened (infected with life-threatening symptoms, detected);  fraction of population in threatened stage;  Infected individuals;  fraction of the population in each stage at day 1; 
H:  Healed;  healed (recovered);  fraction of population in hospitalized stage;  Healed individuals;  fraction of the population in each stage at day 1; 
E:  Extinct;  extinct (dead);  fraction of population in expired stage;  Deceased individuals;  fraction of the population in each stage at day 1; 
Susceptible:  susceptible to infection; 
Exposed:  exposed to infection; 
Infectious:  infected with the virus; 
Removed:  recovered from the virus; 
Risk Perception:  the effect of risk perception on the spread of the virus; 
Cumulative Cases:  the total number of cases; 
Dead Individuals:  individuals who have died from the virus; 
Clinical Severity:  the clinical severity of COVID-19; 
Stochastic Transmission:  transmission dynamics of the virus; 
Basic Reproduction Number:  estimated number of transmissions; 
SIR model:  model for human-to-human transmission; 
SEIR model:  model considering risk perception and cumulative number of cases; 
SIDARTHE model:  model predicting the evolution of epidemics; 
Lockdown:  strategy to contain the spread of the infection; 
Testing:  important to detect undetected infected people;  extent of social restriction and testing; 
R0:  basic reproduction number;  basic reproduction number;  Reproduction number of the virus;  Reproduction number;  Transmission rate; 
R1.66:  social distancing, awareness of the epidemic, hygiene and behavioral recommendations; 
R1.80:  screening focused on symptomatic individuals; 
R1.60:  partially incomplete lockdown effectiveness; 
SOI:  Severity of Infection classification; 
CFR:  Case Fatality Rate;  Ratio of deaths to total number of infected people;  mortality coefficient;  number of deaths in the infected population;  Ratio between the number of deaths ascribed to the infection and the number of diagnosed cases;  Case fatality rate; 
Cumulative infected:  Total number of infected people; 
Current total infected:  Number of currently infected people; 
Recovered:  Number of people who have recovered from the virus; 
Deaths:  Number of people who have died from the virus; 
Diagnosed cumulative infected:  Total number of people diagnosed as infected; 
Diagnosed current total infected:  Number of people currently diagnosed as infected; 
Diagnosed recovered:  Number of people who have been diagnosed as recovered; 
ICUs:  insufficient number of ICUs; 
lockdown measures:  control measures of varying strength and nature; 
transmission rate:  estimated transmission rate; 
diagnosis campaigns:  campaigns to detect SARS-CoV-2 immunoglobulins IgM and IgG; 
Mortality rate:  number of deaths in the whole population; 
Social restriction:  measures that reduce the spread of SARS-CoV-2; 
New drugs and vaccines:  ongoing innovations; 
Case fatality:  excess case fatality; 
α:  transmission rate due to contacts between a susceptible subject and an infected subject;  parameter magnitude of relative epidemiological information;  Infection rate;  Social-distancing countermeasures;  Transmission parameters, related to lockdown measures;  Increases all the curves;  Infection coefficient;  transmission coefficient;  Transmission coefficient; 
β:  transmission rate due to contacts between a susceptible subject and a diagnosed subject;  parameter magnitude of relative epidemiological information;  Transmission rate;  Transmission parameters, related to lockdown measures;  Increases all the curves;  Infection coefficient;  transmission coefficient; 
γ:  transmission rate due to contacts between a susceptible subject and an ailing subject;  parameter magnitude of relative epidemiological information;  Recovery rate;  Social-distancing countermeasures;  Transmission parameters, related to lockdown measures;  Increases all the curves;  Infection coefficient;  Transmission coefficient; 
δ:  transmission rate due to contacts between a susceptible subject and a recognized subject;  parameter magnitude of relative epidemiological information;  Transmission rate;  Transmission parameters, related to lockdown measures;  Increases all the curves;  Infection coefficient;  Transmission coefficient; 
ε:  probability rate of detection of asymptomatic cases;  Constant;  parameter magnitude of relative epidemiological information;  Infection rate;  Decreases all the curves;  Testing coefficient; 
ζ:  probability rate at which an infected subject not aware of being infected develops clinically relevant symptoms;  parameter magnitude of relative epidemiological information;  Testing parameter;  Decreases final number of infected and recovered, increases number of deaths;  worsening coefficients leading to clinically relevant symptoms; 
η:  probability rate at which an infected subject aware of being infected develops clinically relevant symptoms;  parameter magnitude of relative epidemiological information;  Testing parameter;  Decreases final number of infected and recovered, increases number of deaths;  worsening coefficients leading to clinically relevant symptoms; 
θ:  probability rate of detection of symptomatic cases;  Constant;  parameter magnitude of relative epidemiological information;  Testing parameter;  Decreases all the curves;  Testing coefficient; 
λ:  probability rate at which an infected subject not aware of being infected is diagnosed;  rate of recovery for infected subjects;  parameter magnitude of relative epidemiological information;  Healing parameter;  Decreases all the curves, apart from the curve of recovered patients;  healing coefficient; 
ρ:  probability rate at which an infected subject aware of being infected is diagnosed;  rate of recovery for infected subjects;  parameter magnitude of relative epidemiological information;  Healing parameter;  Decreases all the curves;  healing coefficients; 
μ:  probability rate at which an ailing subject is recognized;  rate at which undetected infected subjects develop life-threatening symptoms;  Constant;  parameter magnitude of relative epidemiological information;  Testing parameter;  Decreases final number of infected and recovered, increases number of deaths;  worsening coefficients leading to life-threatening symptoms; 
κ:  probability rate at;  rate of recovery for infected subjects;  parameter magnitude of relative epidemiological information;  Healing parameter;  Decreases all the curves;  healing coefficients; 
ν:  rate at which detected infected subjects develop life-threatening symptoms;  parameter magnitude of relative epidemiological information;  Testing parameter;  Decreases final number of infected and recovered, increases number of deaths;  worsening coefficients leading to life-threatening symptoms; 
τ:  mortality rate for infected subjects with life-threatening symptoms;  parameter magnitude of relative epidemiological information;  Healing parameter;  Leaves all the curves almost unaffected;  mortality coefficient; 
ξ:  rate of recovery for infected subjects;  parameter magnitude of;  Healing parameter;  Decreases all the curves;  healing coefficients; 
σ:  rate of recovery for infected subjects;  Healing parameter;  Decreases all the curves;  healing coefficients; 
H(t):  cumulative variable that depends on other variables and its own initial conditions; 
E(t):  cumulative variable that depends on other variables and its own initial conditions;  number of deaths; 
u:  Feedback signal; 
S(t):  The number of susceptible individuals at time t; 
I(t):  The number of infected individuals at time t; 
D(t):  The number of diagnosed individuals at time t;  number of currently infected individuals with different SOI (asymptomatic or pauci-symptomatic, quarantined at home; 
A(t):  The number of asymptomatic individuals at time t; 
R(t):  The number of recovered individuals at time t;  symptomatic and hospitalized; 
T(t):  The number of deceased individuals at time t;  symptomatic in life-threatening conditions, admitted to ICUs; 
F:  Constant; 
b:  Constant; 
f0:  Constant; 
M(t):  Actual CFR; 
P(t):  Perceived CFR; 
ρD: ; 
ξR: ; 
σT: ; 
ϕ(t): ; 
G.G., F.B. and P.C.:  Authors who proposed the model and performed the mathematical derivations, the fitting and the simulations.; 
R.B., A.D.F., A.D.M. and M.C.:  Authors who provided first-hand insight into the disease evolution and provided the clinical contextualization and interpretation of the results.; 
ECU residents:  People living in the ECU area.; 
Intensive care unit:  People in the intensive care unit.; 
Paediatric unit:  People in the paediatric unit.; 
Virology staff:  Staff members in the virology department.; 
Virology technical staff:  Technical staff in the virology department.; 
Virology residents:  Residents in the virology department.; 
Pharmacy unit:  People in the pharmacy unit.; 
Hospital Leadership:  Leaders of the hospital.; 
Data unit:  People in the data unit.; 
χ:  rate at which immunity is lost; 
Cohen's d:  effect size; 
Pearson's r:  effect size; 
Matlab R2017b:  software; 
Italian Ministry of Health:  data source; 
ChIP-seq:  method; 
Flow cytometry:  Technique for analyzing and sorting particles, such as cells, by measuring their light scattering and fluorescent characteristics.; 
Palaeontology:  Study of fossils and the history of life on Earth.; 
MRI-based neuroimaging:  Technique for imaging the structure and function of the brain using magnetic resonance imaging.; 
Animals and other organisms:  Living organisms studied in research.; 
Human research participants:  People who take part in research studies.; 
Clinical data:  Data collected from medical records and other sources related to patient care.; 
